THE BEST SIDE OF KEYTRUDA COST

Review Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Sign: Together with chemotherapy, with the treatment of adult clients with locally recurrent unresectable or metastatic triple-unfavorable breast cancer who have not obtained prior chemotherapy for metastatic disorder and whose tumours Categorical programmed mobile death-ligand 1